Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Ca Finance Yahoo

Published November 16, 2026 · Updated November 17, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Yahoo! Finance Canada

Read the full story at Ca Finance Yahoo

Ketamine Amid Ongoing Supply Shortage GH Research […] ... NRx Pharmaceuticals Launched U.S.-Made Preservative-Free Ketamine Amid Ongoing Supply Shortage.

Surfaced by this Google Alert

  • Ketamine